Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with stage III, stage IV, or relapsed breast cancer, confirmed through tissue testing and biopsy.
- People who are aged 18 to 75 years old.
- People who have waited at least 2 weeks since their last chemotherapy or radiation treatment, and at least 2 weeks since last taking steroid or immune-suppressing medicines.
- People whose side effects from chemotherapy have settled down.
- People whose cancer cells test positive for certain target proteins — GD2, CD44v6, or Her2 — based on laboratory testing of tumour tissue.
- People with a good general level of physical functioning, meaning they are fully active or able to carry out light work (confirm with trial site for exact definition).
- People whose doctors expect them to survive for at least 12 weeks.
- People whose blood counts and bone marrow function meet minimum levels set by the trial (confirm with trial site for exact values).
- People whose kidney and liver function test results fall within the ranges required by the trial.
- People whose blood oxygen level is 90% or above.
- People who are willing and able to give written consent before any trial procedures begin.
Who may not be able to join:
- People whose tumour is blocking their airway.
- People with a history of epilepsy or other conditions affecting the brain or nervous system.
- People who need to take steroid medicines or other immune-suppressing treatments on an ongoing basis.
- People with a history of serious heart rhythm problems involving a prolonged QT interval (confirm with trial site for exact definition).
- People who have taken part in another clinical trial or received an experimental drug within the 28 days before the trial start date, or who have previously been in this study.
- People whose kidney or liver function test results fall outside the limits set by the trial.
- People who are pregnant or breastfeeding.
- People who have a serious active infection at the time of screening.
- People with an active HIV, hepatitis B, or hepatitis C infection, or any infection that is not under control.
- People who, in the opinion of the trial doctors, may not be suitable or may have difficulty following the study requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 0755-86573763
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with adverse events.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.